Carolyn Bertozzi Returns to Eli Lilly and Company Board of Directors 2025 / OncoDaily

oncodaily - Eli Lilly and Company has announced the election of Carolyn R. Bertozzi, Ph.D., as a returning member of its Board of Directors, effective December 8, 2025. In her renewed role, […]

#healthcare #pharmaceuticals #elililly #biotech #drugdevelopment

Monday, December 15, 2025, 4:22 am / permalink 16960 / 2 stories in 2 months

FDA approves 1st gene therapy for Wiskott-Aldrich syndrome / Beckers

Ella Jeffries / beckershospitalreview - The FDA has approved Waskyra (etuvetidigene autotemcel), the first gene therapy for Wiskott-Aldrich syndrome, a rare and life-threatening immune disorder. Waskyra is indicated for pediatric patients 6 months and older, as well as adults with Wiskott-Aldri…

#healthcare #pharmaceuticals #publichealth #biotech #drugdevelopment #fda

Monday, December 15, 2025, 2:21 am / permalink 16954 / 4 stories in 2 months

Zoliflodacin shows promise as single-dose treatment for gonorrhea

A Phase III trial has demonstrated that zoliflodacin – a single-dose oral antibiotic – is highly effective against drug‐resistant gonorrhea, offering an innovative solution to a mounting public health threat. The encouraging results suggest a potential game‐changer in the fight against antibiotic-resistant infections.

#healthcare #pharmaceuticals #publichealth #drugdevelopment

Saturday, December 13, 2025, 8:21 pm / permalink 16937 / 2 stories in 2 months

Mobile Health Tool May Improve Quality of Life for Adolescent and Young Adult Breast Cancer Survivors / American Association for Cancer Research

Kathleen Medora / aacr - SAN ANTONIO – A mobile health (mHealth) intervention for adolescent and young adult breast cancer survivors that offered tailored support by monitoring electronic patient-reported outcomes (ePROs) significantly improved quality of life and symptoms relate…

#healthcare #publichealth

Saturday, December 13, 2025, 9:21 am / permalink 16922 / 6 stories in 2 months

Menopausal Hormone Therapy May Not Pose Breast Cancer Risk for Women With BRCA Mutations / American Association for Cancer Research

Kathleen Medora / aacr - SAN ANTONIO – Using menopausal hormone therapy (MHT) was not associated with an increased risk of breast cancer in women with inherited mutations in the BRCA1 or BRCA2 genes, according to the results of a matched prospective analysis presented at the San …

#healthcare #publichealth

Saturday, December 13, 2025, 9:21 am / permalink 16921 / 3 stories in 2 months

Adding Tucatinib to First-line Maintenance Therapy Delayed Disease Progression in HER2-positive Metastatic Breast Cancer in HER2CLIMB-05 Trial / American Association for Cancer Research

Kathleen Medora / aacr - Benefit was seen across all subgroups, including in patients with brain metastasis SAN ANTONIO – Adding tucatinib (Tukysa) to first-line maintenance therapy with trastuzumab (Herceptin) and pertuzumab (Perjeta) delayed disease progression in patients with…

#healthcare #pharmaceuticals #drugdevelopment

Saturday, December 13, 2025, 4:21 am / permalink 16917 / 6 stories in 2 months

King Charles III to speak about his cancer treatment, recovery on TV show / ABC News

go - King Charles III will speak about his cancer diagnosis and recovery during a TV broadcast on Friday as the monarch continues to use his personal story to encourage others to get the early screening that can boost their chances of survival

#healthcare #publichealth

Saturday, December 13, 2025, 4:21 am / permalink 16916 / 4 stories in 2 months

Dueling Democrat, Republican ACA subsidy plans fail in Senate / Fierce

fiercehealthcare - Dueling partisan proposals to address the expiry of the Affordable Care Act subsidies both failed to advance in the Senate on Thursday.

#healthcare #publichealth #governmentpolicy

Saturday, December 13, 2025, 3:21 am / permalink 16914 / 7 stories in 2 months

Sacituzumab govitecan-hziy led to similar progression-free survival as standard of care for some breast cancers: Trial / Medical Express

medicalxpress - Patients with hormone receptor (HR)-positive, HER2-negative advanced breast cancers had similar progression-free survival (PFS) whether they were treated with sacituzumab govitecan-hziy (Trodelvy) or standard-of-care chemotherapy as the first treatment af…

#healthcare #pharmaceuticals #drugdevelopment

Saturday, December 13, 2025, 1:21 am / permalink 16912 / 5 stories in 2 months

Tanning beds mutate skin cells far beyond the reach of ordinary sunlight, study shows / Medical Express

medicalxpress - Tanning bed use is tied to almost a three-fold increase in melanoma risk, and for the first time, scientists have shown how these devices cause melanoma-linked DNA damage across nearly the entire skin surface, reports a new study led by Northwestern Medic…

#healthcare #publichealth

Saturday, December 13, 2025, 12:21 am / permalink 16910 / 2 stories in 2 months

Texas sues Epic over alleged EHR monopoly / Healthcare Dive

Emily Olsen / healthcaredive - The suit also accuses Epic of restricting parents’ access to children’s medical records. Epic called the complaint “flawed and misguided.”

#healthcare #publichealth #governmentpolicy #corporatetakeover

Friday, December 12, 2025, 11:23 am / permalink 16881 / 4 stories in 2 months

AHA President Rick Pollack to retire by end of 2026 / Fierce

fiercehealthcare - Longtime American Hospital Association President Rick Pollack will retire by the end of 2026, the organization announced on Wednesday.

#healthcare #publichealth #governmentpolicy

Wednesday, December 10, 2025, 6:23 pm / permalink 16812 / 3 stories in 3 months

Novel Endocrine Therapy Giredestrant Improves Disease-free Survival Over Standard of Care for Patients With Early-stage Breast Cancer in Phase III lidERA Trial / American Association for Cancer Research

Kathleen Medora / aacr - SAN ANTONIO – The investigational, oral selective estrogen receptor degrader (SERD) giredestrant given as an adjuvant therapy showed significant improvement in invasive disease-free survival (iDFS) compared with the current standard-of-care endocrine ther…

#healthcare #pharmaceuticals #publichealth #biotech #drugdevelopment

Wednesday, December 10, 2025, 11:22 am / permalink 16789 / 15 stories in 3 months

ACA approval hits new high as subsidies set to expire: 7 things to know / Beckers

Alan Condon / beckershospitalreview - Approval of the ACA recently climbed to a new high of 57% — driven largely by a surge in support among independents — even as pandemic‑era enhanced subsidies are set to expire Dec. 31 unless Congress acts, according to a survey published Dec. 8 by the Wes…

#healthcare #drugpricing #publichealth #governmentpolicy

Monday, December 8, 2025, 12:22 pm / permalink 16702 / 21 stories in 3 months

A single shot of HPV vaccine may be enough to fight cervical cancer, study finds / ABC News

go - A new study suggests a single HPV vaccination appears just as effective as two doses at preventing the viral infection that causes cervical cancer

#healthcare #publichealth #vaccinesafety

Monday, December 8, 2025, 12:21 am / permalink 16678 / 3 stories in 3 months

CVS Health agrees to pay $37.8M to settle fraud allegations over insulin pens / Fierce

fiercehealthcare - CVS Health agreed to pay $37.76 million to settle allegations that it dispensed too many insulin pens to patients and improperly billed federal healthcare programs for those prescriptions.

#healthcare #pharmaceuticals #drugpricing #publichealth #corporatetakeover

Monday, December 8, 2025, 12:21 am / permalink 16679 / 2 stories in 3 months

Will All Newborns Still Receive Hepatitis B Shots? A Committee’s Vote Will Tell. / NYT

Apoorva Mandavilli / nytimes - The federal vaccine panel appointed by Health Secretary Robert F. Kennedy Jr. is likely to decide on Thursday that the shots should be delayed for infants whose mothers test negative for the virus.

#healthcare #publichealth #governmentpolicy #cdc #vaccinesafety

Sunday, December 7, 2025, 10:22 am / permalink 16672 / 6 stories in 3 months

California Discourages Wild Mushroom Foraging After Fatal Outbreak / NYT

Hannah Ziegler / nytimes - Officials said one person was killed and 20 others were poisoned after eating death cap mushrooms, which look and taste like safe mushrooms but can cause liver failure.

#healthcare #publichealth #governmentpolicy

Saturday, December 6, 2025, 8:21 pm / permalink 16668 / 3 stories in 3 months

Startup Protego Bio Lands $130M for First-in-Class Drug’s Pivotal Test in Rare Plasma Disorder / MedCity

Frank Vinluan / medcitynews - Protego Biopharma’s lead program is a potential treatment for the rare disease light chain amyloidosis. The startup says the novel mechanism of its oral small molecule should have better outcomes than antibodies from AstraZeneca and Prothena that failed t…

#healthcare #pharmaceuticals #publichealth #biotech #drugdevelopment

Saturday, December 6, 2025, 10:21 am / permalink 16661 / 2 stories in 3 months